Analysts expect double-digit growth for pharma major even if Q1 disappointed
Brand named Kerendia (finerenone) will cost Rs 97.5 per day as treatment cost in India
Finds links to Hawala sale of medicines to Afghanistan
In a Q&A, Rehan A Khan talks about his firm's strong focus on R&D and its commitment to making drugs affordable
The Union Ministry of Health has made amendments to the Drugs Rules, 1945, to implement this
The government is engaging with the drug manufacturers to ramp up the production of an antifungal drug used for the treatment of mucormycosis, says Chemicals and Fertilizers Ministry
The company pleaded guilty to concealing and destroying records prior to a 2013 US Food and Drug Administration (FDA) plant inspection, the Department of Justice said
To support its argument, Patanjali has released a bunch of scientific papers on its research for a Covid-19 medicine that was published in popular peer-reviewed journals
Have increased raw material buffer stock by at least 40 days in recent months
Indian firms with specialty product portfolios will do better than peers
Europe is the third-largest market for Indian drug makers after the US and Africa